Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 3/11/2024Johnson & Johnson Completes Acquisition of Ambrx
  • 3/7/2024Novo Nordisk Expects Chinese Approval for Weight Loss Drug Wegovy This...
  • 3/6/2024Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...
  • 3/3/2024AstraZeneca Signs $475 Million Deal for Innovative Drug Facility in Wu...
  • 3/3/2024Bitterroot Bio and Biotheus Enter Research Partnership to Develop Bisp...
  • 3/3/2024Mabwell Out-Licenses Ex-China Rights of Rare Disease Drug to Disc Medi...
  • 3/3/2024Haihe and Taiho Enter Exclusive License Deal for Anticancer Gumarontin...
  • 3/1/2024Financial-related Company News Digest (February 2024)
  • 2/28/2024BeiGene Defies Biotech Winter with Workforce Expansion and Sales Surge...
  • 2/28/2024AstraZeneca Chooses Shanghai as Fifth Global Strategic Center, Reinfor...
  • 2/26/2024BeiGene Ends Partnership with Shoreline in Cell Therapy Venture
  • 2/26/2024Beijing Haidian District Unveils Measures to Boost High-Quality Develo...
  • 2/26/2024Danone Report Robust China Growth, Fueled by Infant and Medical Nutri...
  • 2/26/2024Mabwell Terminates Licensing Deals with Yangtze River Pharma for Two C...
  • 2/26/2024Despite Challenges, German MNCs Plans Increased Investments in China
  • 2/26/2024Nhwa Pharma Licenses China Commericialization Rights of Teva's AUSTEDO...
  • 2/22/2024Domestic Drugmakers Showcased Remarkable Innovation and Global Expansi...
  • 2/21/2024Sinopharm Offers to Take HK-listed China-TCM Private in Nearly US$3B D...
  • 2/20/2024AlphaGen and ARTBIO Announce Strategic Deal for the Development and Co...
  • 2/19/2024Everest Ends Covid-19 Vaccine Deal With Canada's Providence
  • 2/19/2024IMD: China Is Becoming Tech, Pharma Powerhouse
  • 2/19/2024Gilead and Biocytogen Strike a Multi-Target Antibody Collaboration Dea...
  • 2/15/2024LianBio Completes Strategic Review for Winding Down of Its Operations
  • 2/8/2024China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023
  • 2/7/2024I-Mab to Divest China Operations and Become a US-Focused Biotech
  • 2/6/2024 Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
  • 2/6/2024Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
  • 2/5/2024Eisai Encouraged by Market Potential of Its Alzheimer's Drug Leqembi i...
  • 2/5/2024U.S. Congress Postpones Legislation Targeting Chinese Biotech Firms
  • 2/5/2024CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
  • Page:2/13 Total number of articles:372: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group